Home > Clinical Trials

Saved trials

Recruiting
NCT03463317
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
1,512 Enrollment(s)
26 Study location(s)
Interventional (Phase IV)
Atrial Fibrillation
Completed
NCT00441350
Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
1,004 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT04459585
A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants
20 Enrollment(s)
1 Study location(s)
Interventional (Early Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Completed
NCT01014624
Prasugrel/Clopidogrel Maintenance Dose Washout Study
56 Enrollment(s)
4 Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Not yet recruiting
NCT04719481
Pravastatin Reduces Acute Phase Response of Zoledronic Acid
110 Enrollment(s)
0 Study location(s)
Interventional (Phase IV)
Postmenopausal Osteoporosis
Enrolling by invitation
NCT03271450
The DARE Warfarin CER Study
416,000 Enrollment(s)
1 Study location(s)
Observational
Deep Venous Thrombosis
Pulmonary Embolism
Completed
NCT04223635
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
16 Enrollment(s)
2 Study location(s)
Interventional (Early Phase I)
Moderate Hepatic Impairment
Completed
NCT03291288
Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
32 Enrollment(s)
11 Study location(s)
Interventional (Phase I)
Drug Interaction Potential